About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Herceptin Drug Increases the Chance of Survival in Breast Cancer Patients

by Venkatraman on September 27, 2007 at 12:41 PM
Font : A-A+

Herceptin Drug Increases the Chance of Survival in Breast Cancer Patients

A new study has revealed that women with advanced breast cancer can live longer by taking the drug Herceptin, even after they have suffered a relapse.

The finding is based on data from the Hermine trial, an observational study involving 340 women with advanced HER2-positive breast cancer.

Advertisement

Herceptin is the only HER2-targeted therapy proven to extend lives in both early and advanced stages of the disease.

The researchers found that the average survival rate for those who continued to take the drug after the disease progressed was 27.8 months, as compared to the 16.8 months for patients who gave it up.
Advertisement

This means that women with the disease are three times more likely to be alive two years later compared to those who do not take the treatment.

Dr Murray Brunt, clinical oncologist at the University Hospital of North Staffordshire NHS Trust, said that the data provides evidence that Herceptin therapy should be continued beyond progression.

"This data is very welcome and provides evidence supporting the continuation of Herceptin therapy beyond disease progression for women with this particularly aggressive form of breast cancer," the Daily Mail quoted him, as saying.

"It appears that maintaining Herceptin therapy alongside chemotherapy to provide continuous suppression of HER2 may enhance the effectiveness of chemotherapy, and help keep the cancer under control for longer," he added.

Herceptin works by binding to the part of the tumour essential for growth, preventing cell division, thus causing the tumour to stop growing or even shrink.

The study was released at the European Cancer Congress in Barcelona.

Specialists believe that Herceptin therapy is the most important development in breast cancer treatment for 25 years.

Source: ANI
VEN /J
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Memory Loss - Can it be Recovered?
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Drug Toxicity Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Signature Drug Toxicity Breast Cancer Facts Cancer Facts Cancer 

Recommended Reading
New Breast Cancer Therapies
A gene that plays a linchpin role in the ability of breast cancer cells to respond to estrogen have ...
Breast Biopsy
Breast biopsy involves removing a sample of breast tissue to determine whether it is cancerous or .....
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Mastitis
Mastitis is a common cause of tenderness, swelling and pain in breast, owing to inflammation in the ...
Pagets disease of the breast
A detailed description of the Paget's disease of the breast, characteristic signs and symptoms, dete...
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of l...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use